1. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020; 382(13):1199–1207. PMID:
31995857.
2. Mahase E. Covid-19: WHO declares pandemic because of “alarming levels” of spread, severity, and inaction. BMJ. 2020; 368:m1036. PMID:
32165426.
![crossref](/image/icon/bnr_ref_cross.gif)
3. World Health Organization. Coronavirus Disease 2019 (COVID-19): Situation Report, 126. Geneva: World Health Organization;2020.
4. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054–1062. PMID:
32171076.
![crossref](/image/icon/bnr_ref_cross.gif)
5. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382(18):1708–1720. PMID:
32109013.
6. Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA. 2020; 323(16):1574–1581.
![crossref](/image/icon/bnr_ref_cross.gif)
7. Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003; 426(6965):450–454. PMID:
14647384.
![crossref](/image/icon/bnr_ref_cross.gif)
8. Patel AB, Verma A. COVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what is the evidence? JAMA. Forthcoming. 2020; DOI:
10.1001/jama.2020.4812.
![crossref](/image/icon/bnr_ref_cross.gif)
9. Vaduganathan M, Vardeny O, Michel T, McMurray JJ, Pfeffer MA, Solomon SD. Renin-angiotensin-aldosterone system inhibitors in patients with COVID-19. N Engl J Med. 2020; 382(17):1653–1659. PMID:
32227760.
![crossref](/image/icon/bnr_ref_cross.gif)
12. Korean Society of Infectious Diseases. Korea Centers for Disease Control and Prevention. Analysis on 54 mortality cases of coronavirus disease 2019 in the Republic of Korea from January 19 to March 10, 2020. J Korean Med Sci. 2020; 35(12):e132. PMID:
32233161.
13. Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020; 8(4):e21. PMID:
32171062.
![crossref](/image/icon/bnr_ref_cross.gif)
14. Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. Forthcoming. 2020; DOI:
10.1001/jama.2020.4683.
![crossref](/image/icon/bnr_ref_cross.gif)
15. Diaz JH. Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19. J Travel Med. 2020; 27(3):taaa041. PMID:
32186711.
![crossref](/image/icon/bnr_ref_cross.gif)
16. Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020; 17(5):259–260. PMID:
32139904.
![crossref](/image/icon/bnr_ref_cross.gif)
17. Kuster GM, Pfister O, Burkard T, Zhou Q, Twerenbold R, Haaf P, et al. SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19? Eur Heart J. 2020; 41(19):1801–1803. PMID:
32196087.
![crossref](/image/icon/bnr_ref_cross.gif)
18. Danser AHJ, Epstein M, Batlle D. Renin-angiotensin system blockers and the COVID-19 pandemic: at present there is no evidence to abandon renin-angiotensin system blockers. Hypertension. 2020; 75(6):1382–1385. PMID:
32208987.
20. de Miguel-Díez J, Jiménez-García R, Hernández-Barrera V, Maestu LP, Aparicio IJ, Ramos AO, et al. Clustering of unhealthy lifestyle behaviors is associated with a low adherence to recommended preventive practices among COPD patients in Spain. COPD. 2014; 11(4):459–467. PMID:
24568374.
![crossref](/image/icon/bnr_ref_cross.gif)
21. Li J, Wang X, Chen J, Zhang H, Deng A. Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan, China. JAMA Cardiol. Forthcoming. 2020; DOI:
10.1001/jamacardio.2020.1624.
![crossref](/image/icon/bnr_ref_cross.gif)
22. Zhang P, Zhu L, Cai J, Lei F, Qin JJ, Xie J, et al. Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19. Circ Res. 2020; 2020; 126(12):1671–1681. PMID:
32302265.
23. Mizumoto K, Kagaya K, Zarebski A, Chowell G. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Euro Surveill. 2020; 25(10):2000180.
![crossref](/image/icon/bnr_ref_cross.gif)
24. Oran DP, Topol EJ. Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review. Ann Intern Med. 2020; M20–3012.
25. Chang MC, Seo WS, Park D, Hur J. Analysis of SARS-CoV-2 screening clinic (including drive-through system) data at a single university hospital in South Korea from 27 January 2020 to 31 March 2020 during the COVID-19 outbreak. Healthcare (Basel). 2020; 8(2):E145. PMID:
32466523.
![crossref](/image/icon/bnr_ref_cross.gif)